Liquid Biopsy: The Potential to Revolutionize Cancer Diagnostics and Treatment
Issued Date
2023-12-01
Resource Type
ISSN
01252208
Scopus ID
2-s2.0-85182221784
Journal Title
Journal of the Medical Association of Thailand
Volume
106
Issue
12
Start Page
1167
End Page
1171
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand Vol.106 No.12 (2023) , 1167-1171
Suggested Citation
Molek R., Vichitvejpaisal P., Lamlertthon W. Liquid Biopsy: The Potential to Revolutionize Cancer Diagnostics and Treatment. Journal of the Medical Association of Thailand Vol.106 No.12 (2023) , 1167-1171. 1171. doi:10.35755/jmedassocthai.2023.12.13918 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/95614
Title
Liquid Biopsy: The Potential to Revolutionize Cancer Diagnostics and Treatment
Author(s)
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
The present article delved into the potential of liquid biopsy to revolutionize cancer diagnostics and treatment by addressing the current challenges in the field. Liquid biopsy, a non-invasive procedure, involves the detection and analysis of biomarkers in bodily fluids, offering advantages over traditional tissue biopsies. It provides a promising solution to the need for real-time monitoring, personalized treatment approaches, early detection, and minimal residual disease assessment in cancer care. By exploring various applications, such as early detection, treatment monitoring, minimal residual disease assessment, genetic profiling, personalized medicine, and prognostic evaluation, liquid biopsy emerges as a valuable tool in advancing cancer diagnostics and treatment. The present article also discussed current developments, future directions, and provided case studies and success stories showcasing the impact of liquid biopsy. Overall, liquid biopsy holds great promise in transforming cancer care by enabling early detection, personalized treatment decisions, and real-time monitoring of tumors.